Kim Jaehyup, Usmani Amena, De Simone Nicole, Sarode Ravi
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Transfus Apher Sci. 2018 Feb;57(1):46-49. doi: 10.1016/j.transci.2017.11.029. Epub 2017 Nov 24.
Transfusion of donor red blood cells (RBCs) remains an important part of management of sickle cell disease (SCD). However, the survival characteristics of transfused donor RBCs in SCD patients have not been well studied. We sought to calculate survival kinetics of transfused RBCs in SCD patients since it is unclear whether transfused RBCs get destroyed at faster rate as innocent bystander or persist longer due to decreased destruction capacity such as functional splenectomy.
and methods Forty-one SCD patients who had undergone at least 3 RBC exchange procedures were inlcuded. Interval between the procedures, both pre-procedure and post procedure hematocrits, HbA% and HbS% were collected. We developed a mathematical model to calculate RBC lifespan for donor RBCs.
Donor RBCs exhibited average lifespan of about 120days (121.1±13.9 days), which was similar to reported survival of RBCs in normal recipients. However, significant variation between patients were observed with lifespan ranging from 75.6-148.5 days. Intrapersonal variations were small in most cases.
The calculated survival of donor RBCs in SCD recipient, based on certain laboratory values, appears to be similar to that of normal recipient. However, inter-personal variations were large, suggesting different RBC kinetics in a subset of patients, which calls for further research to better understand underlying pathophysiology. This knowledge of RBC survival would be very helpful in individualized management of patients on chronic RBCx.
输注供体红细胞(RBC)仍然是镰状细胞病(SCD)治疗的重要组成部分。然而,SCD患者中输注的供体红细胞的存活特征尚未得到充分研究。由于尚不清楚输注的红细胞是作为无辜旁观者以更快的速度被破坏,还是由于诸如功能性脾切除等破坏能力降低而持续更长时间,我们试图计算SCD患者中输注红细胞的存活动力学。
纳入了41例至少接受过3次红细胞置换程序的SCD患者。收集程序之间的间隔、程序前和程序后的血细胞比容、HbA%和HbS%。我们开发了一个数学模型来计算供体红细胞的红细胞寿命。
供体红细胞的平均寿命约为120天(121.1±13.9天),这与正常受者中报道的红细胞存活率相似。然而,观察到患者之间存在显著差异,寿命范围为75.6 - 148.5天。在大多数情况下,个体内差异较小。
根据某些实验室值计算出的SCD受者中供体红细胞的存活率似乎与正常受者相似。然而,个体间差异很大,表明一部分患者存在不同的红细胞动力学,这需要进一步研究以更好地理解潜在的病理生理学。这种红细胞存活的知识对于慢性红细胞置换患者的个体化管理将非常有帮助。